Kubasch, A. S., Peterlin, P., Cluzeau, T., Götze, K. S., Sockel, K., Teipel, R., . . . Ades, L. (2023). Efficacy and safety of bemcentinib in patients with advanced myelodysplastic neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase II BERGAMO trial. Leukemia, 37(11), . https://doi.org/10.1038/s41375-023-02029-1
Chicago-Zitierstil (17. Ausg.)Kubasch, Anne Sophie, et al. "Efficacy and Safety of Bemcentinib in Patients with Advanced Myelodysplastic Neoplasms or Acute Myeloid Leukemia Failing Hypomethylating Agents- the EMSCO Phase II BERGAMO Trial." Leukemia 37, no. 11 (2023). https://doi.org/10.1038/s41375-023-02029-1.
MLA-Zitierstil (9. Ausg.)Kubasch, Anne Sophie, et al. "Efficacy and Safety of Bemcentinib in Patients with Advanced Myelodysplastic Neoplasms or Acute Myeloid Leukemia Failing Hypomethylating Agents- the EMSCO Phase II BERGAMO Trial." Leukemia, vol. 37, no. 11, 2023, https://doi.org/10.1038/s41375-023-02029-1.